| Literature DB >> 21684846 |
Swastika Ganguly1, Vatsal Vijay Vithlani, Anup Kumar Kesharwani, Ritu Kuhu, Lakshmanan Baskar, Papiya Mitramazumder, Ashok Sharon, Abhimanyu Dev.
Abstract
A series of 1-(2-methyl-4-nitro-imidazol-1-yl)-3-arylaminopropan-2-ones (2a-e), 2-methyl-5-nitro-1-{2-[arylmethoxy]ethyl}-1H-imidazoles (5a-d), and N-(3-hydroxyphenyl)-2-(substituted imidazol-1-yl)alkanamides (8a-e) were synthesized with the aim to develop novel imidazole analogs with broad-spectrum chemotherapeutic properties. Title compounds were evaluated for their anti-HIV and antibacterial activities.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21684846 DOI： 10.2478/v10007-011-0018-2
Source DB: PubMed Journal: Acta Pharm ISSN： 1330-0075 Impact factor: 2.230